What is Express Scripts'(esrx) stock price?
Express Scripts trades on the NASDAQ under the ticker symbol "ESRX." What is Express Scripts' stock price today? One share of ESRX stock can currently be purchased for approximately $92.33.
Is Express Scripts efficiently growing its dividend?
Express Scripts does not have a long track record of dividend growth. In the past three months, Express Scripts insiders have not sold or bought any company stock. Only 0.79% of the stock of Express Scripts is held by insiders. 84.87% of the stock of Express Scripts is held by institutions.
How much of Express Scripts'stock is owned by institutions?
84.87% of the stock of Express Scripts is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Earnings for Express Scripts are expected to grow by 4.63% in the coming year, from $9.08 to $9.50 per share.
Is Express Scripts'stock overvalued or undervalued?
The P/E ratio of Express Scripts is 13.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 18.08. Express Scripts has a PEG Ratio of 1.16. PEG Ratios above 1 indicate that a company could be overvalued. Express Scripts has a P/B Ratio of 2.89.
See more
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada.
Headlines
Are Express Scripts Holding Company’s (NASDAQ:ESRX) Interest Costs Too High?
Express Scripts (NASDAQ:ESRX) Frequently Asked Questions
Express Scripts Holding (NASDAQ:ESRX) posted its quarterly earnings data on Wednesday, October, 31st. The company reported $2.43 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $2.42 by $0.01. The company earned $25.56 billion during the quarter, compared to analysts' expectations of $25.11 billion.
What is ExpressScripts?
Express Scripts operates as a pharmacy benefit management company in the United States and Canada. Its PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves patients, self-funded plans, health plans, regulated markets, workers’ compensation, physicians, and pharmacists. It operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies as of December 31, 2017. Aristotle Holding that began operation in 1986 became Express Scripts Holding Company in April 2012, with its headquarters in Saint Louis in Missouri. Express Scripts operates as a subsidiary of Cigna as of December 20, 2018.
Where is Express Scripts located?
Aristotle Holding that began operation in 1986 became Express Scripts Holding Company in April 2012, with its headquarters in Saint Louis in Missouri. Express Scripts operates as a subsidiary of Cigna as of December 20, 2018.